Literature DB >> 20367893

Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects.

S M Burke1, E van de Giessen, M de Win, T Schilt, M van Herk, W van den Brink, J Booij.   

Abstract

BACKGROUND: Serotonin and dopamine neurotransmitter systems are implicated in the regulation of mood, cognition and personality traits and their dysfunction is thought to be implicated in diverse psychopathologies. However, in healthy subjects the relationship between the serotonin and dopamine systems and neuropsychological functioning and personality traits is not clearly established. In the present study we investigated whether neuropsychological functioning, personality traits and mood states of a group of healthy subjects are associated with in vivo measures of serotonin transporters (SERTs) and dopamine transporters (DATs).
METHOD: A total of 188 young healthy subjects underwent neuropsychological and subjective measurements of memory function, depression and impulsivity. Participants' SERT and DAT availability in predefined regions of interest were assessed using single photon emission computed tomography (SPECT) with the radiotracer [123I]β-CIT. Individual magnetic resonance imaging (MRI) scans served as anatomic reference.
RESULTS: We did not find any significant association between SERT or DAT availability and neuropsychological test performance or self-reported impulsivity and mood. There were no significant sex differences in SERT or DAT availability, but men performed significantly better on some tests of visuospatial functioning than women.
CONCLUSIONS: Robust negative findings for striatal DAT availability seriously question earlier findings of positive associations between DAT availability and cognitive functions in healthy subjects. Our results also suggest that subcortical SERT availability is not associated with the neuropsychological functions and personality traits assessed. In summary, the present study suggests that neuropsychological and personality measurements in young healthy people are not associated with subcortical SERT or striatal DAT availabilities in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367893     DOI: 10.1017/S0033291710000486

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  5 in total

Review 1.  What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?

Authors:  Paul Cumming; Daniele Caprioli; Jeffrey W Dalley
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  Reduced Dopamine Transporter Availability and Neurocognitive Deficits in Male Patients with Alcohol Dependence.

Authors:  Che-Hung Yen; Yi-Wei Yeh; Chih-Sung Liang; Pei-Shen Ho; Shin-Chang Kuo; Chang-Chih Huang; Chun-Yen Chen; Mei-Chen Shih; Kuo-Hsing Ma; Giia-Sheun Peng; Ru-Band Lu; San-Yuan Huang
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

3.  Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults.

Authors:  Christopher T Smith; M Danica San Juan; Linh C Dang; Daniel T Katz; Scott F Perkins; Leah L Burgess; Ronald L Cowan; H Charles Manning; Michael L Nickels; Daniel O Claassen; Gregory R Samanez-Larkin; David H Zald
Journal:  Transl Psychiatry       Date:  2018-12-07       Impact factor: 6.222

4.  Processing speed is related to striatal dopamine transporter availability in Parkinson's disease.

Authors:  Chris Vriend; Tim D van Balkom; Corné van Druningen; Martin Klein; Ysbrand D van der Werf; Henk W Berendse; Odile A van den Heuvel
Journal:  Neuroimage Clin       Date:  2020-04-21       Impact factor: 4.881

5.  Analysis of Polymorphic Variants of the Dopamine Transporter (DAT1) Gene Polymorphism and Personality Traits Among Athletes.

Authors:  Monika Michałowska-Sawczyn; Milena Lachowicz; Anna Grzywacz; Aleksandra Suchanecka; Jolanta Chmielowiec; Krzysztof Chmielowiec; Jakub Chycki; Grzegorz Trybek; Piotr Żmijewski; Paweł Cięszczyk
Journal:  J Hum Kinet       Date:  2020-03-31       Impact factor: 2.193

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.